QRG Capital Management Inc. Has $107.63 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

QRG Capital Management Inc. grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.7% during the third quarter, Holdings Channel reports. The firm owned 184,080 shares of the healthcare conglomerate’s stock after purchasing an additional 4,917 shares during the period. UnitedHealth Group accounts for about 1.2% of QRG Capital Management Inc.’s portfolio, making the stock its 11th largest position. QRG Capital Management Inc.’s holdings in UnitedHealth Group were worth $107,628,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Kathleen S. Wright Associates Inc. acquired a new stake in shares of UnitedHealth Group in the third quarter worth $27,000. Macroview Investment Management LLC lifted its position in UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after acquiring an additional 47 shares during the last quarter. Delos Wealth Advisors LLC grew its position in shares of UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after purchasing an additional 53 shares during the last quarter. Bbjs Financial Advisors LLC acquired a new position in shares of UnitedHealth Group during the 2nd quarter worth about $31,000. Finally, Global Wealth Strategies & Associates increased its position in UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after buying an additional 32 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on UNH shares. Jefferies Financial Group upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and raised their price objective for the stock from $481.00 to $647.00 in a research note on Wednesday, July 17th. TD Cowen boosted their price objective on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday, October 18th. Cantor Fitzgerald lifted their target price on UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 16th. Morgan Stanley reduced their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. Finally, Bank of America cut their target price on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus target price of $615.53.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $565.47 on Monday. The stock has a market capitalization of $522.17 billion, a P/E ratio of 36.87, a price-to-earnings-growth ratio of 1.66 and a beta of 0.58. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $608.63. The firm has a 50 day moving average of $581.96 and a 200-day moving average of $542.45. The company has a current ratio of 0.91, a quick ratio of 0.88 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. During the same period last year, the company posted $6.56 earnings per share. The firm’s quarterly revenue was up 9.2% compared to the same quarter last year. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.49%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.